#Japan #Tokyo #ACL Reconstruction #Stryker Japan #ProCinch

Stryker Japan Launches ProCinch Device for ACL Reconstruction

Stryker Japan Co., Ltd., headquartered in Shinjuku, Tokyo, has announced the upcoming release of its groundbreaking device, ProCinch, designed specifically for anterior cruciate ligament (ACL) reconstruction surgeries. This innovative product will be available in orthopedic clinics across the nation starting September 2026.

Stryker Japan is a subsidiary of Stryker Corporation, a global leader in medical technology headquartered in Michigan, USA. The company has a strong history in sports medicine, where it has developed products such as arthroscopy systems, meniscus repair devices, and artificial ligaments. The introduction of ProCinch marks a significant step into the realm of ACL surgeries, allowing Stryker to offer comprehensive solutions for knee joint treatments, including tibial osteotomy and artificial knee joint surgeries.

Understanding ACL and Its Importance

The ACL is a crucial ligament located at the center of the knee, connecting the femur and tibia and ensuring knee stability. ACL tears are among the most frequent knee injuries encountered in sports. With ProCinch, surgeons can secure graft ligaments to both the femur and tibia during arthroscopic ACL reconstruction, which plays a vital role in restoring knee stability for patients.

ProCinch has been meticulously designed with the surgeon's ease of use in mind. Its speed shuttle feature significantly facilitates the handling of non-absorbable sutures, ensuring that the surgical procedure runs smoothly. Additionally, the device is marked in a loop section to help surgeons easily confirm and adjust the fixation during the procedure.

Clinical evaluations indicate that the reconstructed ACL can sometimes loosen post-surgery, negatively impacting the patient's quality of life. However, the ProCinch device has demonstrated exceptionally low levels of loosening and deformation during high-load testing, indicating that it possesses excellent fixation properties. It has been tested for strength levels significantly exceeding the actual loads encountered in knee joints, which is expected to enhance knee stability for patients over the long term.

Supporting Patients in Their Recovery

By adding ProCinch to its lineup of knee ligament reconstruction solutions, Stryker Japan aims to support a greater number of patients in their return to daily life and sports activities. The company's continued focus on enhancing medical technology promises to contribute positively to patient outcomes.

The ProCinch ACL Reconstruction System comes with medical device approval number 30800BZX00044000, showcasing its compliance with regulatory standards.

For more information on ProCinch and Stryker Japan's innovative products, visit www.stryker.com/jp.

About Stryker Japan

Established as a subsidiary of Stryker Corporation, Stryker Japan is dedicated to serving medical professionals and improving healthcare through cutting-edge medical technology. The company provides a wide range of innovative medical devices and services across various fields, including surgery, neurotechnology, and orthopedics. Each year, Stryker's efforts contribute to the well-being of over 150 million patients worldwide, emphasizing its commitment to healthcare excellence.